about
Brexpiprazole: so far so goodTranscriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor DysregulationAre self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient study.Preliminary data concerning the reliability and psychometric properties of the Greek translation of the 20-item Subjective Well-Being Under Neuroleptic Treatment Scale (SWN-20)Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.Treatment outcomes in schizophrenia: qualitative study of the views of family carersProductivity loss and resource utilization, and associated indirect and direct costs in individuals providing care for adults with schizophrenia in the EU5.State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effectsRole for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in MiceThe effect of add-on memantine on global function and quality of life in schizophrenia: A randomized, double-blind, controlled, clinical trial.Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire.TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical triPersonality traits predicting quality of life and overall functioning in schizophrenia.
P2860
Q26766401-F8DBD6F9-CA58-440F-874B-F4B46FAEDB58Q28555095-9DEC3763-B7C6-40D5-952F-F9EC6D2E8FC4Q31064023-C0B1BBF9-6125-4184-9741-4B75D712C688Q33401710-6C2AA226-B6CA-4A64-BF1F-AF6E583F737EQ33604654-DF2444DD-841A-4D8F-AE70-A5BA68FD7BAEQ33922627-529F8548-5105-4A9C-910B-FD5EF9730B9FQ36332188-96367BFB-3C76-41CC-8DEE-7A077B272E5DQ36732752-7353DB25-431D-41E8-B814-829E7C080C15Q36794968-923E8935-9381-4EC2-A58D-B695945102B4Q41098334-E27B1006-10C8-4F7F-8B1D-B219704D3936Q41859677-43C9BE9A-A700-46B6-BC5E-F2A3336E539CQ42031334-2B1FA0D2-1F50-4ADA-92BA-A5506BEDEF60Q47643668-0C761364-4E20-4B95-9769-765A1326FD11
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Quality of life in schizophrenic patients.
@ast
Quality of life in schizophrenic patients.
@en
type
label
Quality of life in schizophrenic patients.
@ast
Quality of life in schizophrenic patients.
@en
prefLabel
Quality of life in schizophrenic patients.
@ast
Quality of life in schizophrenic patients.
@en
P2093
P2860
P1476
Quality of life in schizophrenic patients.
@en
P2093
Julio Bobes
Manuel Bousoño
Maria Paz Garcia-Portilla
Maria Teresa Bascaran
Pilar Alejandra Saiz
P2860
P304
P577
2007-01-01T00:00:00Z